Recommended videos you might also like
11:58
Patient identification to Follow-up And New Implant Approach
![](https://reachora-public-videos.imgix.net/v/101/b/1/9476b7-8234-4556-bad4-800370284264/thumbnails/image_1.jpg)
01:24
What is Baroreflex Activation Therapy?
![](https://reachora-public-videos.imgix.net/v/101/a/6/e50d3f-ced6-4805-a6c6-690e183b7b3d/thumbnails/image_1.jpg)
17:21
Clinical Results with Baroreflex Activation Therapy (BAT)
![](https://reachora-public-videos.imgix.net/v/101/f/2/ab5040-a495-4edc-bab7-fd53420fd06c/thumbnails/image_1.jpg)
42:23
HRS Symposium 2022
![](https://reachora-public-videos.imgix.net/v/101/f/0/870d29-220f-4320-9300-553a954cdb71/thumbnails/image_1.jpg)
12:32
Barostim case experience and evolving the implant procedure
![](https://reachora-public-videos.imgix.net/v/101/2/6/3e220e-8d88-4634-a99a-9115f622d3a8/thumbnails/image_10.jpg)
16:58
Update on the Clinical Evidence Program for Barostim Therapy
![](https://reachora-public-videos.imgix.net/v/101/3/8/edfd99-dd3b-4daf-8a60-7bfb715f53cf/thumbnails/image_12.jpg)
- Chronic Heart Failure
- Baroreflex Activation Therapy (BAT)
- Chronic Heart Failure – Treatment
- Device Therapy
Expert consensus discussion of CVRx Barostim
854 views
Barostim™ Baroreflex Activation Therapy is a new option for patients with heart failure that utilizes the carotid baroreflex to target autonomic imbalance in the cardiovascular system.
Join the conversation
to comment